Thomas Hoffmann
Martin Luther University of Halle-Wittenberg
4 Papers
40 Citations
Thomas Hoffmann is an academic researcher from Martin Luther University of Halle-Wittenberg. The author has contributed to research in topics: Heart failure & Multiple organ dysfunction syndrome. The author has an hindex of 3, co-authored 3 publications.
Chat about Author
Papers
Autonomic dysfunction predicts mortality in patients with multiple organ dysfunction syndrome of different age groups.
Hendrik Schmidt,Ursula Müller-Werdan,Thomas Hoffmann,Darrel P. Francis,Massimo F Piepoli,Mathias Rauchhaus,Roland Prondzinsky,Harald Loppnow,Michael Buerke,Dirk Hoyer,Karl Werdan +10 more
TL;DR: Autonomic function of MODS patients is blunted, and this attenuation has prognostic implications, which overwhelms and masks the well-known age dependency of autonomic function seen in healthy persons.
279
Impaired chemoreflex sensitivity in adult patients with multiple organ dysfunction syndrome—the potential role of disease severity
Hendrik Schmidt,Ursula Müller-Werdan,Sebastian Nuding,Thomas Hoffmann,Darrel P. Francis,Dirk Hoyer,Mathias Rauchhaus,Mathias Rauchhaus,Karl Werdan +8 more
TL;DR: The calculation of cardiac chemoreflex sensitivity enabled us to quantify an important component of the cardiorespiratory interactions in patients with MODS and has potential to identify a subgroup of patients with worse prognosis.
38
Die autonome Dysfunktion des Herzkranken
TL;DR: Praxisrelevante Messmethoden zu präsentieren, welche Aufschluss über die veränderten kardiorespiratorischen Regelkreise bei Herz- and Kreislauferkrankungen geben.
4
Cryoballoon-ablation of atrial fibrillation in patients with heart failure and preserved ejection fraction
MM Zylla,Joshua H. Leiner,AK Rahm,Thomas Hoffmann,Patrick Lugenbiel,Patrick A. Schweizer,E Scholz,Derliz Mereles,Dorothea Kronsteiner,Meinhard Kieser,Huo Katus,Norbert Frey,D. Thomas +12 more
- 18 May 2022
TL;DR: In this paper , the authors evaluated outcome after cryoballoon-ablation for atrial fibrillation (AF) compared to patients without heart failure employing multiple diagnostic modalities, including stress echocardiography, six-minute-walk-test, biomarker measurements and quality of life assessment.
2